MARKET

RXST

RXST

Rxsight, Inc.
NASDAQ
9.99
-0.47
-4.49%
After Hours: 10.03 +0.04 +0.40% 19:53 01/06 EST
OPEN
10.40
PREV CLOSE
10.46
HIGH
10.51
LOW
9.70
VOLUME
1.00M
TURNOVER
--
52 WEEK HIGH
37.13
52 WEEK LOW
6.32
MARKET CAP
410.76M
P/E (TTM)
-11.3755
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RXST last week (1229-0102)?
Weekly Report · 1d ago
RxSight Inc. to Present at J.P. Morgan Healthcare Conference
Reuters · 4d ago
Weekly Report: what happened at RXST last week (1222-1226)?
Weekly Report · 12/29/2025 09:02
RxSight Announces CFO Transition and Leadership Continuity Plan
TipRanks · 12/23/2025 22:52
RxSight down on CFO transition
Seeking Alpha · 12/23/2025 16:10
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), MDxHealth (MDXH) and RxSight (RXST)
TipRanks · 12/23/2025 12:30
RxSight CFO Shelley Thunen To Transition From Role; Successor Search Underway
NASDAQ · 12/23/2025 05:37
RxSight announces planned transition of longtime CFO Thunen
TipRanks · 12/22/2025 22:52
More
About RXST
RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.

Webull offers Rxsight Inc stock information, including NASDAQ: RXST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXST stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RXST stock methods without spending real money on the virtual paper trading platform.